期刊文献+

绝经后女性慢性心力衰竭患者性激素与心肌损伤指标的关系分析

原文传递
导出
摘要 目的探讨绝经后女性慢性心力衰竭(CHF)患者性激素与心肌损伤指标的关系。方法选择浙江大学医学院附属第二医院临平院区2018年6月—2023年6月诊治的142例绝经后女性CHF患者作为观察组,按心功能分级将其分为32例Ⅰ级、30例Ⅱ级、37例Ⅲ级及43例Ⅳ级;另选取同时期健康体检的100例绝经后女性作为对照组。比较各组性激素[孕酮(P)、垂体泌乳素(PRL)、卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇(E2)及睾酮(T)]与心肌损伤指标[B型尿钠肽(BNP)、心肌肌钙蛋白I(cTnI)及肌酸激酶同工酶(CK-MB)],并分析绝经后女性CHF患者性激素与心肌损伤指标的相关性。结果观察组P、FSH、LH及T分别为(0.42±0.10)ng/ml、(51.03±7.83)mIU/ml、(40.29±9.91)mIU/ml及(1.25±0.30)nmol/L,与对照组的(0.40±0.11)ng/ml、(49.39±8.25)mIU/ml、(41.70±10.11)mIU/ml及(1.23±0.28)nmol/L比较差异均无统计学意义(t=1.380、1.478、1.020、0.498,均P>0.05);观察组PRL、BNP、cTnI、CK-MB[(259.71±36.85)ng/ml、(514.83±81.25)pg/ml、(0.41±0.12)ng/ml、(15.73±3.44)μg/L]比对照组[(185.36±19.01)ng/ml、(83.27±20.52)pg/ml、(0.03±0.01)ng/ml、(3.91±0.83)μg/L]高,E2[(33.46±5.15)pg/ml]比对照组[(42.61±3.75)pg/ml]低(t=18.102、51.629、31.560、33.479、14.593,均P<0.05)。Ⅳ级组PRL、BNP、cTnI、CK-MB[(309.42±31.38)ng/ml、(554.01±88.14)pg/ml、(0.54±0.15)ng/ml、(18.91±4.01)μg/L]比Ⅲ级组[(246.81±40.15)ng/ml、(509.47±76.52)pg/ml、(0.36±0.09)ng/ml、(15.67±3.27)μg/L]、Ⅱ级组[(204.37±37.26)ng/ml、(465.28±70.39)pg/ml、(0.28±0.03)ng/ml、(11.24±2.19)μg/L]与Ⅰ级组[(169.25±23.49)ng/ml、(426.33±65.17)pg/ml、(0.21±0.02)ng/ml、(8.05±1.86)μg/L]高,且Ⅲ级组比Ⅱ级组高,Ⅱ级组比Ⅰ级组高(P<0.05);Ⅳ级组E2[(30.34±4.02)pg/ml]比Ⅲ级组[(33.19±5.17)pg/ml]、Ⅱ级组[(38.26±7.08)pg/ml]与Ⅰ级组[(44.81±9.15)pg/ml]低,且Ⅲ级组比Ⅱ级组低,Ⅱ级组比Ⅰ级组低(F=78.263、11.060、56.181、46.380、19.232,均P<0.05)。Pearson相关分析显示,绝经后女性CHF患者PRL与BNP、cTnI、CK-MB呈正相关,E2与BNP、cTnI、CK-MB呈负相关(r=0.809、0.836、0.799、-0.775、-0.815、-0.792,均P<0.05)。结论PRL、E2与绝经后女性CHF患者BNP、cTnI、CK-MB密切相关,对患者心肌损伤评估具有一定应用价值。
出处 《中国妇幼保健》 CAS 2024年第8期1417-1420,共4页 Maternal and Child Health Care of China
  • 相关文献

参考文献13

二级参考文献128

  • 1袁月,杨媛,孙小燕,王丽蓉,张学红.围绝经期及绝经后期女性骨密度水平及相关影响因素的调查研究[J].兰州大学学报(医学版),2018,0(4):72-77. 被引量:10
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 3Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 4Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 5Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 6Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 7Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 8Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 9Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 10Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.

共引文献3755

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部